| Date | Title | Description | |
|---|---|---|---|
| 25 Apr 2023 | On business and financial situation | ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) | Download | 
| 21 Feb 2023 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download | 
| 21 Feb 2023 | On business and financial situation | The Company releases the full year 2022 financial results presentation. | Download | 
| 21 Feb 2023 | On business and financial situation | The Company releases the press release related to the full year 2022 financial results. | Download | 
| 21 Feb 2023 | On business and financial situation | The company releases the Integrated Report for the year 2022 | Download | 
Pages
| Date | Title | Description | |
|---|---|---|---|
| 09 Jan 2023 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the fourth quarter of 2022 | Download | 
| 15 Dec 2022 | On Corporate Governance | The Company informs about changes in the Board of Directors and the creation of an Advisory Committee. | Download | 
| 04 Oct 2022 | On business and financial situation | The Company informs that it has signed a joint venture agreement with Càrniques Ceirà and Grupo Costa to construct a plant for the production of compounds of high technological value. | Download | 
| 03 Oct 2022 | Liquidity and counterparty agreements | Liquidity contract: transactions conducted in the third quarter of 2022 | Download | 
| 29 Jul 2022 | Other relevant información | On 26 July 2022 the public deed relating to the Company’s share capital decrease was registered with the Commercial Registry of Madrid. | Download | 
Pages
| Date | Title | Description | |
|---|---|---|---|
| 30 Jul 2014 | información sobre resultados | Download | |
| 30 Jul 2014 | información sobre resultados (2) | Download | |
| 01 Jul 2014 | Información sobre dividendos | Download | |
| 12 Jun 2014 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download | |
| 29 Apr 2014 | Información sobre resultados (2) | Download | 







